Perrigo (NYSE:PRGO) Shares Climb 7.6% – Here’s Why

Perrigo Company plc (NYSE:PRGO – Get Free Report) shot up 7.6% during trading on Wednesday. The company traded as high as $16.95 and last traded at $16.9550. 1,347,126 shares changed hands during mid-day trading, a decline of 55% from the average session volume of 2,987,811 shares. The stock had previously closed at $15.76.

Analyst Ratings Changes

PRGO has been the topic of several recent analyst reports. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Perrigo in a research note on Tuesday, November 3rd. Canaccord Genuity Group boosted their price objective on shares of Perrigo from $17.00 to $19.00 and gave the company a “buy” rating in a research report on Friday, October 30th. Wall Street Zen cut shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Saturday, October 31st. Finally, Zacks Research downgraded shares of Perrigo from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 29th. One equities research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $18.50.

Get Our Latest Research Report on Perrigo

Perrigo Trading Up 7.9%

The company has a debt-to-equity ratio of 1.35, a quick ratio of 1.36 and a current ratio of 2.35. The company has a market capitalization of $2.36 billion, a P/E ratio of -1.33, a PEG ratio of 1.74 and a beta of 0.71. The company’s fifty day simple moving average is $15.22 and its 200-day simple moving average is $12.57.

Perrigo (NYSE:PRGO – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.51 by $0.09. Perrigo had a negative net margin of 43.27% and a positive return on equity of 12.39%. The business had revenue of $988.60 million during the quarter, compared to analyst estimates of $984.80 million. During the same quarter in the previous year, the business posted $0.80 EPS. The company’s quarterly revenue was down 5.2% compared to the same quarter last year. Research analysts predict that Perrigo Company plc will post 2.33 earnings per share for the current year.

Perrigo Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Friday, November 27th will be issued a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 6.8%. The ex-dividend date of this dividend is Friday, November 27th. Perrigo’s dividend payout ratio (DPR) is presently -9.09%.

Hedge Funds Weigh In On Perrigo

Large investors have recently bought and sold shares of the business. Salomon & Ludwin LLC purchased a new stake in shares of Perrigo during the 3rd quarter valued at $25,000. Bessemer Group Inc. grew its stake in Perrigo by 69.6% during the 3rd quarter. Bessemer Group Inc. now owns 1,938 shares of the company’s stock worth $29,000 after buying an additional 795 shares during the last quarter. Legacy Trust purchased a new position in Perrigo during the 3rd quarter worth $45,000. Global Retirement Partners LLC grew its stake in Perrigo by 25.3% during the 3rd quarter. Global Retirement Partners LLC now owns 3,784 shares of the company’s stock worth $56,000 after buying an additional 764 shares during the last quarter. Finally, KBC Group NV increased its position in Perrigo by 61.3% during the 1st quarter. KBC Group NV now owns 6,283 shares of the company’s stock valued at $67,000 after buying an additional 2,388 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.

About Perrigo

(Get Free Report)

Perrigo is a global consumer healthcare company that develops, manufactures and markets over-the-counter medicines and other self-care products. Its offerings include treatments for allergies, coughs and colds, pain and digestive health, as well as skin care, oral care and infant nutrition products. The company supplies both its own consumer brands and store-brand products, which retailers sell under their own labels. Perrigo serves customers primarily in North America and Europe through retail and other healthcare channels.

Recommended Stories

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.